Application of 2-acyl-1-dimethylaminomethylferrocene derivative in preparation of drugs for targeted treatment of hepatocellular carcinoma
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HUAQIAO UNIVERSITY
- Publication Date
- 2021-06-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicinal chemistry, and specifically relates to the application of 2-acyl-1-dimethylaminomethyl ferrocene derivatives in the preparation of drugs for targeted treatment of hepatocellular carcinoma. Background technique
[0002] The global burden of hepatocellular carcinoma is increasing and may soon exceed the annual incidence of 1 million cases. Although 40%-50% of patients can receive early diagnosis and treatment through early detection, almost half of liver cancer will eventually develop into advanced liver cancer and receive systemic therapy for advanced liver cancer. However, the current drugs for the treatment of hepatocellular carcinoma have poor targeting and selectivity to cancer cells, accompanied by many serious side effects, resulting in poor therapeutic effect in the treatment of hepatocellular carcinoma. Therefore, it is particularly urgent to discover new, highly effective and less toxic...